Atlas Trials

Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer

Clinical trial NCT03936205 · COMPLETED

Trial details

NCT number
NCT03936205
Sponsor
Hotel Dieu de France Hospital
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Refractory PainMetastatic Cancer
Start date
2016-08-01
Primary completion
2017-10-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.